Drug-coated balloon angioplasty for dialysis access fistula stenosis.
Boitet A, Massy ZA, Goeau-Brissonniere O, Javerliat I, Coggia M, Coscas R.
Semin Vasc Surg. 2016 Dec;29(4):178-185. doi: 10.1053/j.semvascsurg.2016.08.002. Epub 2016 Aug 11.
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A, Al-Atassi T, Oreopoulos G, Roche-Nagle G, Tan KT, Rajan DK.
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD011319. doi: 10.1002/14651858.CD011319.pub2.
The Mechanism of Balloon Impact in Percutaneous Transluminal Coronary Angioplasty in Eccentric Coronary Artery Narrowings.
Saner H, Saner B, Meier B.
Am J Cardiol. 2021 May 1;146:128-131. doi: 10.1016/j.amjcard.2021.01.031. Epub 2021 Feb 3.
Percutaneous radial access for peripheral transluminal angioplasty.
Coscas R, de Blic R, Capdevila C, Javerliat I, Goëau-Brissonniere O, Coggia M.
J Vasc Surg. 2015 Feb;61(2):463-8. doi: 10.1016/j.jvs.2014.07.009. Epub 2014 Aug 15.
Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
Horie K, Tanaka A, Taguri M, Inoue N.
J Endovasc Ther. 2020 Jun;27(3):481-491. doi: 10.1177/1526602820914618. Epub 2020 Apr 6.
Drug-coated percutaneous balloon catheters.
Betala JV, Langan Iii EM, LaBerge M.
Crit Rev Biomed Eng. 2014;42(3-4):193-212. doi: 10.1615/critrevbiomedeng.2014011578.
Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.
Nathan S, Rao SV.
Curr Cardiol Rep. 2012 Aug;14(4):502-9. doi: 10.1007/s11886-012-0287-5.
SIroliMus coated angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION (IMPRESSION): study protocol for a randomized controlled trial.
Pang SC, Tan RY, Choke E, Ho J, Tay KH, Gogna A, Irani FG, Zhuang KD, Toh L, Chan S, Krishnan P, Lee KA, Leong S, Lo R, Patel A, Tan BS, Too CW, Chua J, Tng RKA, Tang TY, Chng SP, Chong TT, Tay HT, Yap HY, Wong J, Dharmaraj RB, Ng JJ, Gopinathan A, Loh EK, Ong SJ, Yoong G, Tay JS, Chong KY, Tan CS.
Trials. 2021 Dec 20;22(1):945. doi: 10.1186/s13063-021-05920-3.
Ageless benefits of transradial access for percutaneous coronary revascularization.
Kim SM, Moliterno DJ.
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):973-4. doi: 10.1002/ccd.26305.
Short- and long-term functional effects of percutaneous transluminal angioplasty in hemodialysis vascular access.
van der Linden J, Smits JHM, Assink JH, Wolterbeek DW, Zijlstra JJ, de Jong GHT, van den Dorpel MA, Blankestijn PJ.
J Am Soc Nephrol. 2002 Mar;13(3):715-720. doi: 10.1681/ASN.V133715.
